ANNOVIS BIO INC's ticker is ANVS and the CUSIP is 03615A108. A total of 30 filers reported holding ANNOVIS BIO INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $83,427 | -33.6% | 8,791 | +0.0% | 0.00% | – |
| Q2 2023 | $125,609 | -7.2% | 8,790 | +0.1% | 0.00% | – |
| Q1 2023 | $135,361 | +14.8% | 8,784 | +0.0% | 0.00% | – |
| Q4 2022 | $117,955 | -2.5% | 8,783 | +0.0% | 0.00% | – |
| Q3 2022 | $121,000 | +22.2% | 8,782 | +0.0% | 0.00% | – |
| Q2 2022 | $99,000 | -15.4% | 8,781 | +0.0% | 0.00% | – |
| Q1 2022 | $117,000 | -24.5% | 8,777 | 0.0% | 0.00% | – |
| Q4 2021 | $155,000 | -50.0% | 8,777 | -10.2% | 0.00% | – |
| Q3 2021 | $310,000 | +559.6% | 9,777 | +1720.7% | 0.00% | – |
| Q2 2021 | $47,000 | +4600.0% | 537 | +2048.0% | 0.00% | – |
| Q1 2021 | $1,000 | – | 25 | +8.7% | 0.00% | – |
| Q4 2020 | $0 | – | 23 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 23 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 48,941 | $464,450 | 0.22% |
| Redmond Asset Management, LLC | 34,080 | $323,419 | 0.12% |
| Sterling Investment Advisors, Ltd. | 34,374 | $326,209 | 0.11% |
| Wescott Financial Advisory Group, LLC | 41,607 | $394,850 | 0.07% |
| Worth Venture Partners, LLC | 12,321 | $116,926 | 0.07% |
| Koshinski Asset Management, Inc. | 15,000 | $142,350 | 0.02% |
| Merit Financial Group, LLC | 41,200 | $390,988 | 0.01% |
| FNY Investment Advisers, LLC | 1,133 | $10 | 0.01% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 300,000 | $2,847,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 23,600 | $223,964 | 0.01% |